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Channel blockThe inner pore of potassium channels is targeted by many ligands of intriguingly different chemical structures.
Previous studies revealed common and diverse characteristics of action of ligands including cooperativity of
ligand binding, voltage- and use-dependencies, and patterns of ligand-sensing residues. Not all these data are
rationalized in published models of ligand-channel complexes. Here we have used energy calculations with
experimentally deﬁned constraints to dock ﬂecainide, ICAGEN-4, benzocaine, vernakalant, and AVE0118 into
the inner pore of Kv1.5 channel. We arrived at ligand-binding models that suggest possible explanations for
different values of the Hill coefﬁcient, different voltage dependencies of ligands action, and effects of mutations
of residues in subunit interfaces. Two concepts were crucial to build the models. First, the inner-pore block of a
potassium channel requires a cationic “blocking particle”. A ligand, which lacks a positively charged group, blocks
the channel in a complexwith a permeant ion. Second, hydrophobicmoieties of a ﬂexible ligand have a tendency
to bind in hydrophobic subunit interfaces.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The human genome encodes 78 proteins that form homo- and
heteromeric potassium channels [1]. Large variations in the gating
mechanisms, physiological and pharmacological characteristics of
potassium channels underline their key roles in the cell physiology, par-
ticularly in regulating excitability of neurons and muscle cells. Many
small-molecule ligands of dramatically different chemical structures
bind in the inner-pore region of potassium channels [1]. The inner-
pore blockers of Kv1.5 channels (Fig. 1) include hydrophobic cations
like bupivacaine [2], ﬂecainide and vernakalant [3] aswell as uncharged
ligands with polar and aromatic moieties, e.g., benzocaine [4], AVE0118
[5], S0100176 [6], ICAGEN-4 [7], and PAP-1 [8]. Mutational analysis of
the Kv1.5 channel has revealed pore-facing residues in the inner helices
(S6s) and P-loop turns that affect binding of ligands [5–7,9,10].
In the absence of X-ray structures of ligand-bound Kv1.5 channel,
homology modeling is the only possibility to suggest structural details
of the ligand binding. To rationalize the experimental data on the
Kv1.5 channel block, several models have been proposed [3,6,7,9–11].
However, some of the experimental data call for further structural anal-
ysis. For example, AVE0118 prevents the channel closure, whereas
S0100176 does not demonstrate this effect [5]. The molecular determi-
nants of this difference are unknown. Another problem is the Hill coef-
ﬁcient. While many compounds demonstrate Hill coefﬁcient about 1,Evolutionary Physiology and
. Tel.: +7 812 552 3138.
Tikhonov).
ights reserved.some compounds block the Kv1.5 channel with the Hill coefﬁcient
greater than one. Examples (Fig. 1) include di-substituted cyclohexyl
derivatives like trans-NPCO-DSC [12], catechol derivatives [13],
ICAGEN-4 and MSD-D [7]. Notably, all these ligands are uncharged
cationophilic molecules, which lack ionizable groups. Furthermore, the
voltage dependence of block cannot be explained by a straightforward
mechanism. Typically, action of positively charged compounds is volt-
age dependent, while uncharged blockers are voltage independent in
agreement with the classical Woodhull model [14]. However,
cationophilic blockers also demonstrate the voltage dependence
of action,which is not expected for uncharged ligands.Moreover, some-
times the voltage dependence of cationophilic ligands is opposite to
that of cationic blockers of the inner pore [4].
Furthermore, some mutational data are not easily interpretable. In
particular, the patterns of ligand-sensing residues identiﬁed for charged
and uncharged blockers are similar (Table 1). This is not clear because
the cationophilic inner pore is expected to discriminate charged and un-
charged ligands. Most of ligand-sensing residues face the inner pore in
the Kv1.5 homology models, which are based on available X-ray struc-
tures (Fig. 2A, B). However, despite isoleucine I502 in the inner helix
S6 is exposed into the subunit interface of the pore module rather
than into the inner pore, mutations of I502 affect binding of various
ligands, although to different extent. Models that suggest ligand binding
only in the central pore necessarily consider indirect effects of muta-
tions of this residue on the ligand action. A recentmodel proposes bind-
ing of one Psora-4 molecule in the central pore and four Psora-4
molecules in side pockets between the voltage-sensing helix S4, linker
helix L45, and backsides of S5 and S6 [11]. None of these bindingmodels
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Fig. 1. Chemical structures of some Kv1.5 channel blockers.
979D.B. Tikhonov, B.S. Zhorov / Biochimica et Biophysica Acta 1838 (2014) 978–987demonstrates direct ligand interaction with I502. The authors hypothe-
size that I502 is important for transition of Psora-4 between the central
pore and the side pockets through subunit interfaces. However, I502 af-
fects binding of many structurally diverse ligands, including ligands
with the Hill coefﬁcient of one and charged ligands that would hardly
pass through the hydrophobic interface. It is unlikely that all these li-
gands block the channel by the same mechanism as proposed for
Psora-4. Therefore, an alternative explanation of the role of I502 in the
Kv1.5 ligands action is necessary.
Here,we addressed these unclear issues related to the Kv1.5 channel
block using a molecular modeling approach. Limited precision of ho-
mologymodeling prevents realistic calculation of the binding free ener-
gy and therefore unbiased prediction of the drug binding modes.Table 1
Ligand-sensing residues in P-loops and S6 segments of Kv1.5 and Kv1.3
Channel P-loop S6
Kv1.5
Kv1.3
↓Mutation (usually Ala substitution) decreases the channel-blocking pote
↑Mutation (usually Ala substitution) increases the channel-blocking po
∙Mutation has a weak effect on the channel block by the ligand.
- Not mutated or mutation resulted non-functional channel.
a Underlined characters refer to the wild-type Kv1.5 residues that coDespite these limitations, homology modeling allowed to elaborate hy-
potheses on ligand interactions with potassium and sodium channels,
which are conﬁrmed by model-directed mutational analysis [8,15–18].
Here we have used previously elaborated models as starting points to
explore possibilities of Kv1.5 channel interactionswith different ligands.
On one hand, energy calculations with a homology model allow us to
rule out many hypotheses and ligand-binding modes that are inconsis-
tent with the energetics of ligand–protein interactions. On the other
hand, ligand docking in a homology model usually predicts several
low-energy complexes. Energetics of these complexes cannot be used
as the only criterion of the model correctness.
In view of these limitations of the homologymodeling approach, our
calculations aimed to ﬁnd local energy minima where ligand-channelchannels and their involvement in ligand binding in our modelsa.
Ligand Reference
S0100176
AVE0118
Vernakalant
Flecainide
ICAGEN-4
DPO-1
PAP-1
Correolide
[6]
[5]
[3]
[3]
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ncy of the ligand.
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ntribute to the binding of respective ligand in our models.
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Fig. 2. Ligand-sensing residues and ﬂecainide bindingmodes. A and B, A subunit interface viewed from the central cavity at the angles of ~175 and 90° to the pore axis. Purple and yellow
surfaces represent two adjacent subunits (inner heliceswith P-loops). Green color shows ligand-sensing residues T479, T480, V505, I508 andV512 that line the inner pore. Ligand-sensing
residue I502 in the subunit interface is cyan. C and D, Results of hands-free docking of ﬂecainide. Ensemble of 200 lowest-energy complexes of ﬂecainide in the Kv1.5 open channel model
obtained from 100,000 randomly generated starting ligand orientations. Blue spheres represent the positively charged amino group. In themajority of obtained bindingmodes, the entire
ligandmolecule binds inside the inner pore, but three structures show partial penetration of the ligandmoieties (shown as sticks) in the subunit interface where they reach the I502 res-
idues (space ﬁlled). The low number of such structures in the ensemble reﬂects the fact that random seeding most frequently hits the wide inner pore and only rarely hits the narrow
subunit interface. E and F, the proposed binding mode of ﬂecainide. The positively charged ammonium group of each ligand is located in the cation-attractive region in the central cavity.
Triﬂuoromethyl moiety of the ligand protrudes in a subunit interface and reaches the I502 residue.
980 D.B. Tikhonov, B.S. Zhorov / Biochimica et Biophysica Acta 1838 (2014) 978–987complexes lack sterical hindrances, unfavorable electrostatic interac-
tions and contacts between hydrophobic and hydrophilic moieties.
Among different binding modes that satisfy these criteria we focused
on those, which agree with available experimental data and allowed
us to suggest structural hypotheses explaining various features of the
Kv1.5 channel block.
2. Methods
Our methodology of molecular modeling is described in many stud-
ies, e.g. [8,19–21]. Brieﬂy, we use the ZMM program that minimizesenergy in the space of internal (generalized) coordinates, the Monte
Carlo (MC) energy minimization method [22], the AMBER force ﬁeld
[23,24] with the implicit solvent [25], and atomic charges at ligands,
which are calculated by MOPAC [26]. The homology model of Kv1.5
channel was built using the Kv1.2 open-channel structure [27] as a
template.
Due to limited precision of the homology modeling approach, we
have used “pin” constraints to ensure similarity of the backbone confor-
mation in the model and the template. A pin constraint is a ﬂat-bottom
parabolic energy function that imposes an energy penalty if an alpha
carbon of the model deviates from the template position by more than
981D.B. Tikhonov, B.S. Zhorov / Biochimica et Biophysica Acta 1838 (2014) 978–9871 Å. For all constraints the energy penaltywas calculated using the force
constant of 10 kcal mol−1 Å−2.
Biased ligand docking was performed in few steps. First, the ligand
was placed in a speciﬁc location manually or by using distance con-
straints (penalty functions added to the energy expression). The biased
position of the ligandwasMC-minimized with the distance constraints.
Then the distance constraints were removed and the complex was re-
ﬁned by an additional MC-minimization. If during the reﬁning MC-
minimization the ligand or the ligand-bound metal ion moved away
from the starting geometry, the respective ligand-binding mode was
ignored.
The ensemble of low-energy conformations obtained in the reﬁning
MC-minimization (up to 10 kcal/mol from the apparent global mini-
mum) was used for statistical analysis of ligand-channel interactions.
For each structure the interaction energies between the ligand and all
channel residues were calculated and averaged over the ensemble. If
the absolute value of this average energy for a particular residue was
more than 0.5 kcal/mol, the residuewas considered as a signiﬁcant con-
tributor to the ligand binding.
3. Results
3.1. Ligand-sensing residues in the pore and subunit interfaces
Ligand-sensing residues, which are known from experimental stud-
ies, are shown in Table 1. Mutations of the pore-facing residues V505,
I508 and V512 affect action of various ligands, suggesting that these
ligands bind in the inner pore (Fig. 2A and B). Besides the central
cation-attractive cavity, which is lined by ligand-sensing residues, the
pore module includes rather hydrophobic subunit interfaces lined by
inner helices and the P-helix [1] (Fig. 2A and B). In calcium and sodium
channels, the interface between repeat domains III and IV has been pro-
posed to serve as a sidewalk access pathway to the inner pore [28–30].
Some ligand-sensing residues in potassium, sodium and calcium chan-
nels line these interfaces rather than the central cavity. An example is
I502 in Kv1.5. Mutations of this residue affect block bymany ligands, in-
cluding cationic ligands ﬂecainide and vernakalant (Table 1). Fig. 2B
shows that although I502 (colored cyan and marked by arrow) is ex-
posed to the subunit interface, it is potentially accessible from the pore.
To explore this possibility, we performed hands-free docking of
ﬂecainide to the Kv1.5 open channel model. 100,000 starting points
with random position and orientation of the ﬂecainide molecule in the
inner pore were generated and each starting point was optimized in a
short MCM trajectory of 10 energy minimizations to remove steric
clashes. Fig. 2C and D shows the ensemble of 200 lowest-energy struc-
tures. In most of these structures, the entire drug molecule is located
within in the inner pore. However, in several structures triﬂuoromethyl
group of ﬂecainide penetrated into a subunit interface and approached
I502. The number of such structures is small because during random
generation of the starting points the chances of the ligand to hit the nar-
row interface are much smaller than the chances to occur in the big
inner pore.
The binding models in which Kv1.5 ligands are located entirely in
the inner pore have been carefully examined in several studies, e.g.,
[3,6,7,9–11], which explain mutational data on pore-facing residues in
P-loops and S6s. However, these models do not explain why mutations
of I502 affect drug action. Therefore in this study we focused on the
binding modes where ligands interact directly with I502. We used dis-
tance constraints to near a ligand and I502. Importantly, stability of
the obtained binding modes was checked by unconstrained reﬁning-
stage MC-minimizations (see Methods).
3.2. Flecainide and vernakalant
In the recentmodel of ﬂecainide binding to Kv2.1 [16], which is pro-
posed basing on experimentally determined ﬂecainide-sensingresidues, the ligand piperidine ring ﬁts in the central cavity, while the
benzamide moiety binds in the subunit interface between the S6 and
P helices. In the present study, a homology model of ﬂecainide-Kv1.5
complex was obtained by MC-minimizations (see Methods) using the
model [16] as the starting point. In the ﬁnal lowest-energy structure
(Fig. 2C and D) the charged group is located in the cation-attractive re-
gion of the inner pore, which corresponds to site s5 for a potassium ion.
A triﬂuoromethyl group entered the subunit interface and interacted di-
rectlywith I502. The pattern of residues, which contribute toﬂecainide–
channel interactions (Table 1), agrees with mutational data. Fig. 2E and
F show a representative complex. Characteristics of the ensemble
of low-energy structures are given in Supplementary Fig. S1 and
Table S1. The experimentally revealed ﬂecainide-sensing residues in
Kv1.5 provided 64% of the total binding energy and 30% of this energy
was due to electrostatic interactions of the P-helices with ﬂecainide
charged moiety.
Certain similarities between the chemical structures of ﬂecainide
and vernakalant allowed us to build a vernakalant-Kv1.5 model
(Fig. 3A and B) in which the ligand charged part bound in the inner
pore, whereas the uncharged dimethoxyphenyl moiety protruded in
the subunit interface and interacted directly with I502. Since
vernakalant is larger than ﬂecainide, it occupied more space in the
inner pore and also interacted with residues A509 and V512, which
do not contribute signiﬁcantly to ﬂecainide binding (Tables 1 and S2,
Fig. S2). The only vernakalant-sensing residues, which did not form di-
rect contacts with the ligand in our model, were A501 and C500. Allo-
steric effects of these mutations are proposed earlier [3]. Thus, our
models agree with most of mutational data on the considered here
charged Kv1.5 blockers, including effects of I502 substitutions.
3.3. Model of Kv1.5 with ICAGEN-4
One of the important characteristics of drug action is the Hill coefﬁ-
cient, which reﬂects cooperativity of biding ligand molecules to a pro-
tein. Classical hydrophobic cations, like tetrabutylammonium, block P-
loop channels with the 1:1 stoichiometry (the Hill coefﬁcient of 1),
but many other blockers demonstrate the Hill coefﬁcient N1 suggesting
that at least two ligand molecules block the channel with positive
cooperativity. Structurally diverse molecules block Kv1.5 channels
(and other members of the Kv1 family) with the Hill coefﬁcient N1. Ex-
amples (Fig. 1) are S-nitrosodithiothreitol [31], di-substituted
cyclohexyl derivatives [12], catechol derivatives [13], MSD-D and
ICAGEN-4 [7].
Among compounds, which demonstrate the Hill coefﬁcient N1,
ICAGEN-4 is particularly big and a possibility of binding of more than
one ICAGEN-4 molecule in the inner pore is not obvious. To elaborate
a homology model of Kv1.5 with ICAGEN-4 we have used the concept
of Kv1.3 channel block by a tripartite complex of two electroneutral
PAP-1 molecules and a potassium ion [8]. In the respective model,
which is supported by extensive mutational and structure-activity ex-
periments [8], the inner pore is blocked by a potassium ion that is che-
lated by two psoralen moieties, while long ﬂexible 4-phenoxybutoxy
moieties of PAP-1 molecules protrude in the subunit interfaces. Follow-
ing this concept, we docked a tripartite complex containing two neutral
ICAGEN-4 molecules and a potassium ion into the central cavity of
Kv1.5. Distance constraints were used to near cation-attractive SO2
groups of two ICAGEN-4 molecules to a potassium ion, while terminal
moieties were directed in subunit interfaces.
A representative structure of the MC-minimized complex is shown
in Fig. 3C and D, the ensemble of obtained structures is shown in
Fig. S3 and its energy characteristics are given in Table S3. The ligands
adopted an angular conformation with the methoxyphenyl ends pro-
truding into subunit interfaces and opposite ethylphenyl ends extended
along the inner pore. The escape of the methoxyphenyl ends from the
inner pore provided a room to accommodate two molecules in the
channel. Hydroxyl groups at the vertex of the ligand molecules
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Fig. 3. Proposed bindingmodes of vernakalant, ICAGEN-4 and benzocaine in themodel of Kv1.5. Cytoplasmic (A, C and E) and side (B,D and F) views show the channelwith bound ligands.
Vernakalant (A and B), binds like ﬂecainide (see Fig. 2). However, it is bigger than ﬂecainide, occupies more space in the inner pore and interacts with residues, which are not ﬂecainide
sensing ones (e.g., V512). ICAGEN-4 (C and D) and benzocaine (E and F) form tripartite complexes of two ligandmolecules and a potassium ion at site s5. ICAGEN-4molecules bind in an
angular conformation with one end extending in a subunit interface and the opposite end lining the pore. The SO2 groups chelate a potassium ion, which stabilizes the tripartite complex.
Twomolecules of benzocaine (C and D) also chelate a K+ ion in the inner pore. One molecule binds in the axial orientation, with the aromatic moiety lining the inner pore. Another mol-
ecule binds in a horizontal orientation with the aromatic moiety protruding in the subunit interface, thus resembling binding of an “angular” ICAGEN-4 molecule.
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helices. A potassium ion was chelated at the cavity center by the SO2
groups of the two ligands. Such disposition of the SO2 groups would
be electrostatically unfavorable in the absence of a potassium ion. The
potassium bridge can explain a positive cooperativity for binding two
ligand molecules. Most of the experimentally determined [7] ICAGEN-
4-sensing residues (Table 1) directly interacted with the bound ligands,
including T507 that does not face the inner pore. Thus, the model
allowed us to explain simultaneous binding of two rather big ligands
in the Kv1.5 channel. I502 was not mutated in the work [7]. Our
model predicts that ICAGEN-4 should interact with this residue.
In our model two ICAGEN-4 molecules chelated the ion by their SO2
groups. This interaction is not expected to coordinate a potassium ion
stronger than eight selectivity ﬁlter oxygens do. In our model the blockis achieved by hydrophobic ethylphenylmoieties of two ICAGEN-4mole-
cules that extend along in the inner pore below site s5.
3.4. Model of Kv1.5 with benzocaine
Benzocaine produces dual action on Kv1.5: at nanomolar concentra-
tions it behaves as an agonist by potentiating the current, whereas at
micromolar concentrations it blocks the current [4]. Authors of this
study demonstrated that both types of action aremediated by benzocaine
binding to the inner pore region and that the blocking site overlaps with
the binding site for bupivacaine. Surprisingly, blocking action of neutral
benzocaine is voltage-dependent and the voltage dependence has oppo-
site sign in comparison with the action of cationic drugs. External
tetraethylammonium does not modify the agonistic and blocking
983D.B. Tikhonov, B.S. Zhorov / Biochimica et Biophysica Acta 1838 (2014) 978–987effects of benzocaine, but suppressed the voltage-dependence. More-
over benzocaine and extracellular potassium ions interact to modify
the voltage-dependence of channel opening [4].
To explain these data we propose the following mechanism. At low
concentrations, benzocainewould bindwith high afﬁnity in the “horizon-
tal” orientation in the subunit interface and expose its cation-attractive
moiety towards the inner pore, near the selectivity ﬁlter (molecule 1 in
Fig. 3E and F). Benzocaine molecule in such a binding mode would not
block the cannel, but may increase the current by providing additional
sites for permeating ions. At higher concentrations, the second benzo-
caine molecule would bind in the “vertical” orientation to a low-afﬁnity
site in the inner pore (molecule 2 Fig. 3C, D). The cation-attractivemoiety
of the second molecule would also interact with a potassium ion in the
inner pore, while the hydrophobic moiety, which extends along the
inner pore, would block the permeation. Fig. 3E and F shows only
two benzocaine molecules, but up to four molecules could bind in
the “horizontal” orientation to the same potassium ion, while their
hydrophobic moieties would extend in the subunit interfaces, as
proposed for Kv1.3 channel block by PAP-1 [8]. Ourmodel also explains
an unusual voltage-dependence of benzocaine action. We propose that
neutral ligands coordinate a potassium ion to form a cationic blocking
particle. A positive voltage would push the potassium ion out of the
ligands, thus decreasing stability of the ligand-potassium blocking par-
ticle. The released potassium ion would escape from the inner pore to
the extracellular space through the selectivity ﬁlter (see also ref. [32]).
Non-surprisingly the effect is antagonized by external potassium ions
and tetraethylammonium. The description of the two-barrier model of
the voltage-dependence is given in Supplementary materials.
It should be noted that available mutational data on benzocaine
binding [4] are fragmental and do not allow unambiguous conclusion
about its binding site(s). Therefore, the model visualized in Fig. 3E and
F is schematic and can be considered only as a preliminary hypothesis.
3.5. Model of Kv1.5 with DPO-1
Kv1.5 is blocked by electroneutral compounds like DPO-1 [33] and
clotrimazole [34]. DPO-1 sensing residues, which are found by muta-
tional analysis [35], include T480 and A509 that contribute to binding
of various ligands (Table 1), as well as several residues that do not
face the pore. Notably, I502 is not among the DPO-1 sensing residues.
It should be also noted that mutations of some DPO-1 sensing residues
affect activation characteristics of the Kv1.5 channel [35]. Moreover,
there is a correlation between the shifts of the activation curve induced
by the mutations and their effect on the DPO-1 blocking potency. This
correlation was reported for residues L499, L506, L510, and V514, but
not for the pore-facing residues T480 and I508. Authors of this study
[35] propose that mutations of T480 and I508 decrease the DPO-1
blocking potency by altering the ligand binding site, while other muta-
tions affect the DPO-1 potency by allosteric mechanisms.
A bulky branched DPO-1 molecule contains a highly polarized
P = O bond whose oxygen atom would attract a metal ion. Another
bulky cationophilic ligand, correolide, is proposed to bind in the inner
pore and directly interact by its polar groups with a potassium ion at
site s4 between four threonine residues in the TVGYG motifs [20]. The
Kv1.3 channel block by correolide is also affected by mutations of
some residues that do not line the inner pore [36] and therefore cannot
directly interactwith the big, bulky ligand. Herewe have used a concept
of Kv1.3 channel block by correolide to elaborate amodel of Kv1.5 block
by DPO-1. We have populated the selectivity ﬁlter with potassium ions
at sites s2 and s4 and imposed an initial distance constraint to maintain
proximity between a potassium ion at site s4 and the polar oxygen of
DPO-1. The obtained energetically most preferable binding mode is
shown in Fig. 4A and B, the ensemble of low-energy structures in
Fig. S4, and its energy characteristics are given in Table S4. The central
cavity readily accommodated the bulky DPO-1 molecule. The phospho-
rus atom, which according to MOPAC calculations bears a big positivecharge, occurred in the cation-attractive region at the focus of P-
helices, while the phosphorous-bound negatively charged oxygen
atom retained a close contactwith a potassium ion at site s4. This strong
attraction counterbalanced repulsion of the DPO-1 oxygen from
cationophilic C-ends of the pore helices.
3.6. Models of Kv1.5 with AVE0118 and S0100176
These compounds represent a large group of ﬂexible, uncharged
Kv1.5 ligands [37]. Interestingly, patterns of ligand-sensing residues
for charged (ﬂecainide and vernakalant) and uncharged (AVE0118
and S0100176) Kv1.5 ligands are similar (Table 1). This is an intriguing
problem because the cationophilic inner pore should be attractive for
cationic, but not cationophilic ligands. To address this problem, we
employed the idea that cationophilic groups of ligands may directly in-
teract with permeant cations and thus form cationic blocking particles
[32]. Strutz-Seebohm and coauthors docked uncharged ligands in a ho-
mology model of Kv1.5 and predicted hydrophobic interactions of the
blockers with pore-lining hydrophobic residues and electrostatic inter-
actions of oxygen atoms of the blockers with a potassium ion at site s4
[7]. This binding mode resembles a model of correolide in Kv1.3 [20]
and the binding mode of DPO-1 proposed in the present work.
Since I502 contributes to the binding of AVE0118 (Table 1), we sug-
gested that a part of the ligand binds in the subunit interface like certain
moieties of ﬂecainide, vernakalant and ICAGEN-4.We imposed distance
constraints to bias interactions of both CO groups of AVE0118with a po-
tassium ion. The latter occurred at site s5 in the middle of the central
cavity and established additional π-cation contacts with the AVE0118
molecule.
In the lowest-energy model (Fig. 4C and D) the hydrophobic
methoxyphenyl ring of AVE0118 ﬁtted in the hydrophobic subunit in-
terface and interacted with I502, while bulky pyridine ring remained
in the central cavity. The central part of AVE0118 with two aromatic
rings bound at the P-loop turns and interacted with residues T479 and
T480. The pyridine end of AVE0118 interactedwith the pore-facing res-
idues V505, I508, A509, V512 and V516. Two polar carbonyl groups
interacted with a potassium ion in the middle of the inner pore, thus
forming a cationic blocking particle. The ensemble of low-energy struc-
tures is shown in Fig. S5 and its characteristics are given in Table S5.
AVE0118 and S0100176 are uncharged molecules with similar pat-
terns of ligand-sensing residues, although somemutations have quanti-
tatively different effects on the action of these blockers. Importantly,
while AVE0118 blocks the channel by the foot-in-the-door mechanism,
S0100176 does not prevent the channel closure [5], suggesting a possi-
bility of the trapping block. Our model of AVE0118 binding readily ex-
plains the foot-in-the-door mechanism: the large pyridine ring
occurred at the level of V516 where it would prevent the activation
gate closure. We further docked S0100176 into the Kv1.5 model with
a potassium ion (Fig. 4E, F, Fig. S6 and Table S6) using the samemethod-
ology that was used to dock AVE0118. Some features of the S0100176
and AVE0118 bindingmodes are similar. Two polar groups and the aro-
matic ring of S0100176 coordinated a potassium ion at site s5, near the
focus of P-helices. The NH group bound to the backbone carbonyl at the
C-end of a P-helix. The hydrophobic toluene moiety avoided the pore
and approached I502 in the subunit interface. S0100176 also interacted
with V505, I508, and A509. Unlike AVE0118, S0100176 readily adopted
a “horizontal” orientation in the channel (Fig. 4E, F) and bound above
the activation-gate region where it would not prevent the activation
gate closure in agreement with experimental data [5]. It should be
noted that S0100176 only weakly interacted with I512 and V516. The
toluene moiety of S0100176, which is shorter than methoxyphenyl
moiety of AVE0118, did not penetrate deep into subunit interface and
only weakly interacted with I502. This may explain much larger sensi-
tivity of AVE0118 to the I502 mutation as compared with S0100176
[5,6]. Our models also explain why two long ﬂexible ligands of similar
size demonstrate different mechanisms of block. A terminal moiety at
I502V505V516
V505
I502
V505
I508
T480
DC
T480
I508
V505
T480
V516
A509
V505
V512
I502
I508
T480
T480
805I084T
I508
BA
E F
Fig. 4.Proposedbindingmodes of DPO-1 (A and B), AVE0118 (C andD) and S0100176 (E and F) in theKv1.5 channel. DPO-1 is stabilized by the attraction of oxygen and phosphorus atoms,
respectively, to a potassium ion at site s4 and to the cation-attractive site s5. The DPO-1 molecule interacts directly with T480 in the pore helix and with I505 in the S6 segment. Other
residues whose mutation affect DPO-1 action, do not face the pore. AVE0118 and S0100176 provide an aromatic ring and two polar groups to coordinate a potassium ion in the cation-
attractive region and thus form “cationic blocking particles”. The NH groups approach the backbone oxygens at the C-ends of P-helices. Hydrophobic moieties protrude into subunit in-
terfaces and approach the I502 residue.
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several groups in themiddle chelate a potassium ion at site s5. This sig-
niﬁcantly restricts possible orientations of the opposite end of the ligand
and its particular orientation becomes dependent on ﬁne details of the
ligand structure. In AVE0118, the opposite end extends vertically
along the pore, towards the activations gate, whereas in S0100176 it is
oriented horizontally (see Fig. 4D and F). Thus, our models are consis-
tent with published data on the action of AVE0118 and S0100176.4. Discussion
In this study we proposed binding modes for several Kv1.5 channel
blockers, which belong to different structural classes. To obtain these
models, we applied a homology modeling approach. Some features of
previously proposedmodels have been used to generate starting points
for our docking experiments. The aim of these calculations was toexplorewhether or not the obtainedmodels can rationalize experimen-
tal data on the action of diverse Kv1.5 ligands.4.1. Limitations of modeling
We avoid discussion of structure–activity relationships of Kv1.5 li-
gands due to limited precision of the homologymodels.We used a rath-
er simple force ﬁeld, Coulomb's electrostatics, ﬁxed atomic charges and
implicit solvent. The entropy componentwas not taken into account. As
a result, the precision of energy calculations is limited. This approach
can be categorized as “coarse grain” one; it can reveal major steric, hy-
drophobic and electrostatic determinants of drug binding, but does
not provide the free energy of binding and thus, the drug afﬁnity.
From the other side, simple and fast energy sampling allowed very in-
tensive explorations of the conformational space. Up to 100,000 energy
minimizations were performed in each MCM trajectory. Employment of
985D.B. Tikhonov, B.S. Zhorov / Biochimica et Biophysica Acta 1838 (2014) 978–987more comprehensive force ﬁelds is not necessary for limited-precision
homology models.
We docked ligands only to the open-state Kv1.5 model. Obviously,
changes of the channel geometry during activation and inactivation
can result in the different binding afﬁnity. Fig. S7 shows three residues,
which face the pore and form the entrance to the subunit interface in
the closed, open, and open-inactivated potassium channels. Homo-
logues of these residues, T479, V505 and I508, are key ligand-sensing
residues in Kv1.5. The state-dependent changes in the mutual disposi-
tion of these residues and dimensions of the subunit interface are mod-
est. Such changes are unlikely to explain use-dependency of action.
However, big changes in cytoplasmic halves of S6s upon activation gat-
ing allow to explain why some ligands prevent channel closure, while
others do not. In our models ICAGEN-4 and AVE0118 interact with res-
idues at the cytoplasmic parts of S6, which converge in the closed state.
Such ligands should prevent the channel closure. In contrast, other
docked ligands interact mainly with the upper half of the inner pore,
which does not undergo big rearrangements upon the channel activa-
tion gating.
We used constraints to impose certain features of ligand binding
modes, particularly penetration of hydrophobic moieties in subunit in-
terfaces and interactions of neutral ligands with potassium ions.
Several previously publishedmodels of ligand binding in Kv1.5 considerDPO
CorreoFlecainide
BeAVE0118
A B
C
Fig. 5. Common and distinguishing features of the inner-pore block in P-loop channels. A and B
have been docked into theKv1.5 channel in the presentwork. Potassium ions in sites s1–s5 are s
First, a cationic moiety of a blocking particle (blue dots), which is either a ligand-bound potassi
attractive central cavity of the inner pore. Second, hydrophobic moieties bind in the hydrophob
axis, are shown as red dots. C, The proposed schemes of binding of charged and neutral ligands
can by either a charged group of the ligand or a chelated metal ion. The uncharged moieties ofalternative possibilities, in particular binding of the entire ligand mole-
cule in the inner pore and the channel block by electroneutral ligands
without involvement of permeating metal ions [3,6,7,9–11]. In the
present study we did not attempt to analyze such binding modes:
they are already well explored and additional calculations are unlikely
to provide novel results. Instead, we have focused on possible binding
modes, which were not previously considered.
4.2. Common features of the proposed models
It should be emphasized thatwe have considered here a very diverse
set of ligands. Nevertheless, the proposed ligand-channel models have
important common features, which are illustrated in Fig. 5. A long ﬂex-
ible ligand readily adopts an angular conformation. A hydrophobic end
protrudes into the hydrophobic subunit interface, while the opposite
end binds in the pore and provides the channel block. The central part
of both ﬂexible and bulky ligands can contain a positive charge (the am-
monium group or a phosphorus atom) or/and coordinate a permeant
ion in the cation-attractive region. Combinations of these rather simple
features create a large variety of blocking structureswith different char-
acteristics (Fig. 5).
Except for permanently charged quaternary compounds like
tetraalkylammonium blockers, other cationic blocking particlesVernakalant
-1
lide
nzocaine ICAGEN-4
, Cytoplasmic and side views at the superimposed binding modes of all the ligands, which
hown at B as yellow dots. There are two important common features of the bindingmodes.
um ion, or a protonated nitrogen, or a phosphorus atom in DPO-1, is located in the cation-
ic subunit interfaces. The heavy atoms of the ligands, which aremost distant from the pore
. The cation-attractive site in the inner pore is occupied by the cation (a pink circle), which
the ligands can either extend along the inner pore or protrude into the subunit interfaces.
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gand. Lining of the inner pore by predominantly hydrophobic residues
and local electric ﬁeld in the focus of P-helices favor such attachment
of the positive charge. Parameters of ligand protonation or association
with ametal ion, which are obtained in bulk solvent, are hardly applica-
ble for this speciﬁc environment of the inner pore. Therefore, relative
probabilities of a ligand association with a proton or a metal ion are un-
known. In particular, we cannot rule out that some ligands, which are
considered neutral, may block the channel in the protonated form. Con-
sidering this alternative could affect some structural details of our
models, but not their general features.
4.3. Experimental data in view of the models
Various experimental observations, including results ofmutagenesis
have been rationalized in previously elaborated models [3,6,7,9–11].
Our models are also consistent with these experimental data because,
as in the previous models, the bulky parts of the ligand molecules ﬁt
the inner pore and interact with the pore-facing residues. Below
we discuss only those observations for which our models suggest
novel explanations.
4.3.1. I502
Our models suggest direct interaction of ligands with I502, which is
accessible from the pore through the subunit interface. Substitutions
of I502 decrease potency of ﬂecainide, vernakalant, AVE0118 and
S0100176 (the effect on S0100176 is rather small). Sensitivity of the
ICAGEN-4 action to thismutation is unknown. Among the considered li-
gands, only DPO-1 is completely insensitive to mutations of I502
(Table 1). In ourmodel DPO-1 lacks long arms that could enter the sub-
unit interface. This agrees with our proposition that mutations of I502
affect ligand action directly rather than allosterically.
A recent study provides strong evidences that Psora-4 can bind not
only in the central pore of Kv1.5, but also in side pockets formed by
S4, L45, and backsides of S5 and S6 [11]. The authors suggest that I502
is important for the ligand transition between these sites. We cannot
rule out a possibility that additional binding sites exist for other ligands.
However, it seems unlikely that all so diverse ligands have high-afﬁnity
binding sites andmechanisms of Kv1.5 block similar to those of Psora-4.
Noteworthy, PAP-1 [38], a structural analog of Psora-4, has a long hy-
drophobic tail, which according tomodel [8] can reach the Kv1.3 analog
of I502 in the subunit interface.
4.3.2. Hill coefﬁcient
Cooperative binding of some ligands in Kv1.5 channel, which isman-
ifested as the Hill coefﬁcient N1, calls for structural explanations. One
possibility is allosteric mechanism by which binding of the ﬁrst ligand
induces protein changes that facilitate binding of the second ligands
(see, e.g., Ref. [11]). In this mechanism the ligand molecules do not in-
teract directly and may bind to sites, which are far from each other. In
contrast, our models suggest that the joint chelation of a potassium
ion at site s5 is the structural basis for the cooperative ligand binding
in the inner pore. This hypothesis can explain cooperative binding in
the pore of electroneutral ligands, which have very different chemical
structures.
4.3.3. Voltage dependence of ligand action
The Kv1.5-blocking potency of cationic ligands vernakalant and
ﬂecainide increases with increase of the positive membrane potential
[3]. Electroneutral ligands are not expected to sense the membrane
ﬁeld [39]. However, the inner-pore targeting electroneutral ligands
such as benzocaine [4], SNDTT [31], and ICAGEN-4 [7], do demonstratesome voltage-dependency of their action on Kv1 channels. Intriguingly,
the channel-blocking potency of some electroneutral ligands does not
increase, but decreases with increase of the positive membrane volt-
ages. To explain this we suggest that one ormoremolecules of a neutral
ligand coordinate a potassium ion to form a cationic blocking particle.
The electric ﬁeld breaks such a complex and thus reduces activity. Sup-
plementary Fig. S8 shows prediction of the two-barrier model of the
voltage-dependent block [14].4.3.4. State-dependence of ligand action
Despite we did not model ligand binding in different channel states,
a hypothesis on the mechanism of the state-dependent ligand action
can be suggested in viewof our results. A common feature of ourmodels
is the channel block by a cationic particle,which can be either an organic
cation or a complex of electroneutral ligand(s) with a permeant metal
ion. This common feature suggests a universal role of electrostatic inter-
actions in the inner pore block. Signiﬁcance of electrostatic repulsion
between ions in the selectivity ﬁlter and in the inner pore is known
[40]. In the open channel this repulsion should be weaker than in the
closed channel due to the screening effect of water molecules and the
larger room, which allows the blocking particle to adjust and minimize
the repulsion. The relation between the channel block and slow inacti-
vation can also have an electrostatic nature: coupling between the ion
occupancy of the selectivity ﬁlter and slow inactions is known [41].
The electrostatic mechanism is consistent with state-dependent afﬁnity
of organic cations. This mechanism can be considered as a general expla-
nation for the state-dependent ligand afﬁnity if electroneutral ligands
block the channel not per se, but in a complex with the permeant metal
ion.5. Concluding remarks
Ion channels are among major targets for pharmacological agents.
Elaboration of new drugs remains an important and challenging prob-
lem. Effective search of new promising structures should be based on
understanding of common and distinguishing features of the channel
block by different classes of ligands. In this work we demonstrate that
molecular models, which are based on rather simple concepts about
the mechanisms of channel block, help to rationalize the action of di-
verse Kv1.5 ligands. We believe that the proposed concepts of the
inner pore blockmayhelp analyze action of other drugs targeting potas-
sium channels as well as other P-loop channels.Author contribution
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